Retrospective Analysis of the Efficacy and Safety of Sorafenib in Chinese Patients With Metastatic Renal Cell Carcinoma and Prognostic Factors Related to Overall Survival

Sorafenib has been recommended as first- or second-line treatment for metastatic renal cell carcinoma (mRCC) by several guidelines. The objective of this study is to evaluate the efficacy of sorafenib monotherapy in Chinese patients with mRCC and determine the prognostic clinicopathologic factors as...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Medicine (Baltimore)
Main Authors: Yu, Xiaoteng, Guo, Gang, Li, Xuesong, Zhang, Cuijian, Huang, Lihua, Fang, Dong, Song, Yi, Zhang, Xu, Zhou, Liqun
Formato: Artigo
Idioma:Inglês
Publicado: Wolters Kluwer Health 2015
Assuntos:
5700
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4602909/
https://ncbi.nlm.nih.gov/pubmed/26313773
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MD.0000000000001361
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares